These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9653605)

  • 41. Hormone replacement therapy: estrogen after menopause.
    Gibaldi M
    Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.
    Rodriguez C; Patel AV; Calle EE; Jacob EJ; Thun MJ
    JAMA; 2001 Mar; 285(11):1460-5. PubMed ID: 11255422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heart disease risk factors and hormone use in postmenopausal women.
    Barrett-Connor E; Brown WV; Turner J; Austin M; Criqui MH
    JAMA; 1979 May; 241(20):2167-9. PubMed ID: 430817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.
    Lee SJ; Lee DW; Kim KS; Lee IK
    Diabetes Res Clin Pract; 2001 Dec; 54 Suppl 2():S81-92. PubMed ID: 11733113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Common genetic variation in the prothrombin gene, hormone therapy, and incident nonfatal myocardial infarction in postmenopausal women.
    Hindorff LA; Psaty BM; Carlson CS; Heckbert SR; Lumley T; Smith NL; Lemaitre RN; Rieder MJ; Nickerson DA; Reiner AP
    Am J Epidemiol; 2006 Apr; 163(7):600-7. PubMed ID: 16467413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
    Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
    Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.
    Kerlikowske K; Cook AJ; Buist DS; Cummings SR; Vachon C; Vacek P; Miglioretti DL
    J Clin Oncol; 2010 Aug; 28(24):3830-7. PubMed ID: 20644098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke.
    Floyd JS; Wiggins KL; Christiansen M; Dublin S; Longstreth WT; Smith NL; McKnight B; Heckbert SR; Weiss NS; Psaty BM
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):151-60. PubMed ID: 26547662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
    Jick H; Derby LE; Myers MW; Vasilakis C; Newton KM
    Lancet; 1996 Oct; 348(9033):981-3. PubMed ID: 8855853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus.
    Xu Y; Lin J; Wang S; Xiong J; Zhu Q
    Kaohsiung J Med Sci; 2014 Jul; 30(7):350-61. PubMed ID: 24924841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States).
    Newcomb PA; Trentham-Dietz A
    Cancer Causes Control; 2003 Mar; 14(2):195-201. PubMed ID: 12749724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postmenopausal hormone use and risk for colorectal cancer and adenoma.
    Grodstein F; Martinez ME; Platz EA; Giovannucci E; Colditz GA; Kautzky M; Fuchs C; Stampfer MJ
    Ann Intern Med; 1998 May; 128(9):705-12. PubMed ID: 9556463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
    Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.